What is the appropriate management plan for a patient with perforated diverticulitis and an intra‑abdominal abscess who is being treated with a wound vacuum (wound VAC)?

Management of Perforated Diverticulitis with Abscess in a Patient with Wound VAC

For a patient with perforated diverticulitis, abscess, and an existing wound VAC, the contingency plan depends critically on their hemodynamic status and immune competence: clinically stable immunocompetent patients should continue the staged damage control approach with VAC therapy, planned second-look operation for delayed anastomosis within 36-48 hours, and 4-7 days of antibiotics; critically ill or immunocompromised patients require immediate surgical intervention with Hartmann's procedure. 1, 2

Clinical Assessment Framework

The presence of a wound VAC indicates this patient has already undergone initial damage control surgery. Your immediate priorities are:

• Hemodynamic stability assessment: Heart rate, blood pressure, urine output, lactate levels, need for vasopressors
• Immune status: Immunosuppression, age >70, multiple comorbidities
• Infection control: Temperature trends, white blood cell count, C-reactive protein, procalcitonin
• Abscess characteristics: Size, location (intra-abdominal vs. contained), drainage adequacy

Staged Approach for Stable Patients (Preferred)

If your patient is hemodynamically stable without organ failure, continue the damage control strategy 2, 3:

Stage 1 (Already Completed)

• Limited resection of perforated sigmoid
• Abdominal lavage
• VAC placement

Stage 2 (36-48 Hours Later, During Daytime)

This is your contingency plan window 2:

• Primary colorectal anastomosis if patient has improved clinically (65-76% achieve stoma-free discharge) 2, 3
• Hartmann's procedure if patient deteriorates or fails to improve
• Abdominal closure

Antibiotic Duration

• 4 days if source control is adequate and patient is immunocompetent 1
• Up to 7 days if immunocompromised or critically ill, based on clinical response and inflammatory markers 1

Critical caveat: If signs of infection persist beyond 7 days despite adequate source control, repeat imaging is mandatory to identify ongoing septic foci 1.

Abscess Management Algorithm

The abscess component requires specific attention 1, 4:

Small Abscesses

• Antibiotics alone for 7 days if <3-6 cm 1, 4

Large Abscesses (>3-6 cm)

• Percutaneous drainage + antibiotics for 4 days (preferred) 1
• If percutaneous drainage not feasible:
  • Immunocompetent, stable: Antibiotics alone with close monitoring 1
  • Immunocompromised or critically ill: Surgical intervention 1

Antibiotic Regimens

For Critically Ill or Immunocompromised Patients with Adequate Source Control 1:

• Piperacillin/tazobactam 6g/0.75g loading dose, then 4g/0.5g q6h or 16g/2g continuous infusion
• OR Eravacycline 1 mg/kg q12h

If Inadequate/Delayed Source Control or High ESBL Risk 1:

• Ertapenem 1g q24h
• OR Eravacycline 1 mg/kg q12h

If Septic Shock Develops 1:

• Meropenem 1g q6h by extended/continuous infusion
• OR Doripenem 500mg q8h by extended/continuous infusion
• OR Imipenem/cilastatin 500mg q6h by extended infusion
• OR Eravacycline 1 mg/kg q12h

Beta-lactam Allergy 1:

• Eravacycline 1 mg/kg q12h
• OR Tigecycline 100mg loading dose, then 50mg q12h

Surgical Decision Points at Second Look

Key determinants for proceeding to anastomosis 2, 3:

✓ Proceed to primary anastomosis if:

• Hemodynamically stable off vasopressors
• No ongoing organ failure
• Adequate tissue perfusion
• Minimal peritoneal contamination
• Surgeon expertise available

✗ Perform Hartmann's procedure if:

• Persistent hemodynamic instability
• Multiple major comorbidities
• Ongoing sepsis despite source control
• Fecal (not just purulent) peritonitis 1, 4

Monitoring Requirements

Daily assessment until second-look operation:

• Vital signs and vasopressor requirements
• Urine output (goal >0.5 mL/kg/hr)
• Lactate clearance
• White blood cell count, CRP, procalcitonin trends
• VAC output characteristics (volume, purulence)

Failure indicators requiring immediate surgical revision:

• Worsening hemodynamics despite resuscitation
• Rising lactate or inflammatory markers after 24-48 hours
• Increasing VAC purulent output
• New organ dysfunction

Common Pitfalls to Avoid

1. Premature anastomosis: Attempting reconstruction before adequate physiologic recovery leads to anastomotic leak and mortality 3, 5

2. Inadequate source control: Unrecognized or undrained abscess collections will cause persistent sepsis despite antibiotics 1, 4

3. Antibiotic duration errors: Stopping antibiotics at 4 days in immunocompromised patients or continuing beyond 7 days without investigating for ongoing infection 1

4. Ignoring the "therapeutic window": The 36-48 hour interval is critical for patient optimization—operating too early or too late compromises outcomes 2

Alternative Consideration: Laparoscopic Lavage

Do NOT use laparoscopic lavage as primary treatment in this patient with established perforation and abscess 1, 6. This approach is:

• Controversial and not first-line for peritonitis 1, 4
• Only considered for highly selected patients with purulent (not fecal) peritonitis 1
• Associated with high failure rates in Hinchey III/IV disease 6

The damage control approach with VAC and staged reconstruction has demonstrated superior outcomes with 70-76% achieving bowel continuity and acceptable mortality rates of 9.8-26% in this high-risk population 3, 5.